Trial Profile

Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries (Thunder – Trial)

Status: Active, no longer recruiting

Phase of Trial: Phase II/III

Latest Information Update: 26 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paclitaxel (Primary)
Indications Peripheral arterial disorders; Peripheral arterial occlusive disorders; Restenosis
Focus Therapeutic Use
Acronyms THUNDER

Most Recent Events

03 Nov 2011 Five-year data will be presented at the 2011 Transcatheter Cardiovascular Therapeutics scientific symposium, according to a MEDRAD Interventional media release.
05 Nov 2010 New trial record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com